Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Go back to Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio| Arbios Systems, Inc. (NASDAQ: ABOS) | Delayed: 2.74 +0.15 (5.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.59 | 52 Week High | $0.23 | |||
| Open | $2.62 | 52 Week Low | $0.00 | |||
| Day High | $2.76 | P/E | N/A | |||
| Day Low | $2.62 | EPS | $0.00 | |||
| Volume | 351,238 | |||||
